ReviewNature protocols2024
Comprehensive synthesis of Ti
Review in Nature protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
58 citing papers in PubMed.
- MXene-integrated quantum dots: an innovative tool for next-generation healthcare applications.Nanoscale advances · 2026Review
- Freeze-thaw-directed interfacial assembly of a gold nanoparticle/MXene electrochemical aptamer sensor for antibody-free myeloperoxidase detection.Mikrochimica acta · 2026Article
- Interfacial Synergy in Hierarchical FMWCNTs/α-FePolymers · 2026Article
- Two-Dimensional MXenes for a Sustainable Future.Journal of the American Chemical Society · 2026Article
- Disclosing Trends on C(1s) Core-Level Binding Energies of MXene Flakes: Metal, Size and Edge Effects.The journal of physical chemistry. C, Nanomaterials and interfaces · 2026Article
- Article
- Phonon-Dominated In-Plane Thermal Conductivity of Single-Flake Metallic Ti3C2Tx MXene.Nano letters · 2026Article
- Hydrothermal-Assisted In Situ Intercalation Synthesis of TiSmall methods · 2026Article
- Vertical Graphene Nanowalls Anchored on TiACS applied materials & interfaces · 2026Article
- MXenes for Defense-Oriented Multifunctional Systems: From Synthesis and Property Regulation to Deployment Challenges.Materials (Basel, Switzerland) · 2026Review
- Interfacial Redox-Driven Crystallization on MXene Enables Ultrasensitive HgACS applied materials & interfaces · 2026Article
- Quantum Dot-Based Dual-Fluorescence Aptasensing Platform Using Interface-Engineered MXene for Multiplex Protein Detection.Sensors (Basel, Switzerland) · 2026Article
- One-Step Radical-Intensified Selective Etching (RISE) Strategy for High-Yield Synthesis of Monolayer MXene with Tailored Nanoholes.Angewandte Chemie (International ed. in English) · 2026Article
- Nacre-Inspired Flexible Mxene-Based Films for Multifunctional Applications in Supercapacitors and Piezoresistive Sensors.Sensors (Basel, Switzerland) · 2026Article
- Harnessing Visible Light: MXene/g‑CPrecision chemistry · 2026Article
- Engineering TiRSC advances · 2026Review
- Orientation Engineering of MXene Flakes.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Synergistic interface engineering of Ni-integrated Co-ZIF67 on two-demensional MXene for enhanced oxygen evolution reaction.Scientific reports · 2026Article
- MXene-Based Membranes for Selective Ion Separation.Membranes · 2026Review
- Coupled Biphasic NaMnOEnergy & fuels : an American Chemical Society journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
MXenes are a large family of two-dimensional materials that have attracted attention across many fields due to their desirable optoelectronic, biological, mechanical and chemical properties. There currently exist many synthesis procedures that lead to differences in flake size, defects and surface chemistry, which in turn affect their properties. Herein, we describe the steps to synthesize Ti
Indexed as
Identifiers
38504139What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.